A Florida biopharmaceutical and diagnostics company is paying nearly $1.5 billion in stock for Elmwood Park-based diagnostics laboratory firm Bio-Reference Laboratories Inc.OPKO Health Inc. said ...

Opko Health Inc. has agreed to acquire Bio-Reference Laboratories Inc. in a deal worth $1.47 billion. So What: Bio-Reference Labs is the nation's third largest laboratory services business, and its ...

Good day, ladies and gentlemen, and welcome to the First Quarter 2009 Bio-Reference Laboratories Earnings Conference Call. My name is Erica, and I'll be your coordinator for today. At this time, all ...

Feel free to take Bio-Reference ( BRLI) at its word yet again. That's fine; hold onto that stock, regardless of its vulnerabilities. At least try to arrive at an informed decision, however, by ...

MIAMI--(BUSINESS WIRE)--OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO ...

Bio-Reference Laboratories (Nasdaq: BRLI) is expected to report Q4 earnings around Dec. 6. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year ...

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) today announced the completion of the acquisition of Bio-Reference by OPKO. Shareholders of ...

Good morning, and welcome to the Bio-Reference Laboratories Fourth Quarter and Year End for Fiscal Year 2012 Earnings Conference Call. Bio-Reference Laboratory is one of the largest independent ...

NEW YORK (AP) -- Shares of Bio-Reference Laboratories Inc. rose Thursday after the clinical laboratory testing services provider said it had a strong fiscal fourth quarter despite business disruptions ...

Third party reports are also surfacing claiming that the company's former esoteric darling, GenPap, was in fact a test that was simply bought and used under license from a Korean company, Seegene.

MIAMI--(BUSINESS WIRE)--OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO ...